Showing results (21-30 of 32) with videos related to
Sort By:
Pageof 4
Frontiers in Oncology|May 28, 2020
Talimogene Laherparepvec in Advanced Mucosal Melanoma of the Urethra Upon Primary Resistance on Immune Checkpoint Inhibition: A Case ReportAnne Fröhlich, Friederike Hoffmann, Dennis Niebel, et al.Melanoma Research|February 3, 2023
DNA methylation of GITR, OX40, 4-1BB, CD27 , and CD40 correlates with BAP1 aberrancy and prognosis in uveal melanomaFriederike Hoffmann, Anne Fröhlich, Judith Sirokay, et al.Therapeutic Drug Monitoring|November 14, 2018
Pharmacokinetics of Daclatasvir, Sofosbuvir, and GS-331007 in a Prospective Cohort of Hepatitis C Virus-Positive Kidney Transplant RecipientsEva Schrezenmeier, Friederike Hoffmann, Carsten Jaeger, et al.Environmental Microbiology|May 21, 2009
Complex nitrogen cycling in the sponge Geodia barrettiFriederike Hoffmann, Regina Radax, Dagmar Woebken, et al.Nature Communications|May 22, 2014
Developmental gene expression provides clues to relationships between sponge and eumetazoan body plansSven Leininger, Marcin Adamski, Brith Bergum, et al.Clinical Chemistry|February 1, 2024
Circulating Cell-Free SHOX2 DNA Methylation Is a Predictive, Prognostic, and Monitoring Biomarker in Adjuvant and Palliative Anti-PD-1-Treated MelanomaSimon Fietz, Eric Diekmann, Luka de Vos, et al.Clinical Epigenetics|April 12, 2022
DNA methylation regulates TIGIT expression within the melanoma microenvironment, is prognostic for overall survival, and predicts progression-free survival in patients treated with anti-PD-1 immunotherapyDennis Niebel, Anne Fröhlich, Romina Zarbl, et al.Biomarker Research|May 31, 2023
ICOS DNA methylation regulates melanoma cell-intrinsic ICOS expression, is associated with melanoma differentiation, prognosis, and predicts response to immune checkpoint blockadeDamian J Ralser, Emmanuelle Herr, Luka de Vos, et al.Clinical Epigenetics|July 6, 2023
CTLA4 DNA methylation is associated with CTLA-4 expression and predicts response to immunotherapy in head and neck squamous cell carcinomaFriederike Hoffmann, Alina Franzen, Luka de Vos, et al.Clinical Epigenetics|June 27, 2020
Prognostic and predictive value of PD-L2 DNA methylation and mRNA expression in melanomaFriederike Hoffmann, Romina Zarbl, Dennis Niebel, et al.Pageof 4